儿童常染色体显性多囊肾病表现的多国注册研究解读
基于ADPedKD、ERKReg和RaDaR三个注册研究,分析32个国家超过2100例儿童及青少年ADPKD患者。无症状家族筛查是常见就诊方式(ADPedKD 48%,ERKReg 62%),国际差异大(19%-75%),基因检测率与医疗支出相关,产前异常诊断占14%且逐年增加。
要点
- 无症状家族筛查是儿童ADPKD常见诊断途径,比例48%-62%,国际差异19%-75%。
- 基因检测率与医疗支出显著相关(ERKReg队列OR 1.030/100美元/人/年)。
- 产前异常诊断占14%,2000年后两个注册研究中稳步增加。
核心结论
- 儿童ADPKD诊断以主动筛查为主,家族咨询需求高。
- 基因检测率受经济因素驱动,而主动筛查率差异与文化、法律和伦理框架有关。
研究设计与样本
- 多国注册研究分析,比较ADPedKD(1060例)、RaDaR(269例)和ERKReg(825例)共超过2100例儿童及青少年ADPKD患者,来自32个国家六个WHO区域。
主要发现
- 无症状家族筛查为常见就诊方式:ADPedKD 48%,ERKReg 62%,国际范围19%-75%。
- 两个注册研究中筛查比例时间趋势较稳定,与基因检测无相关性。
- 产前异常诊断占14%,2000年后在两个注册研究中稳步增加。
- ERKReg队列中基因检测率与医疗支出显著相关(OR 1.030每100美元/人/年),随时间变化小。
临床怎么用
- 对ADPKD家族中的儿童应考虑无症状筛查的利弊咨询。
- 基因检测决策需结合经济可及性和家庭意愿。
- 产前发现异常时应考虑ADPKD可能并转诊评估。
局限性
- 数据来自注册研究,可能存在选择偏倚。
- 筛查率和基因检测率的国际差异受文化、法律和伦理框架影响,未能量化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Data on the presentation of Autosomal Dominant Polycystic Kidney Disease (ADPKD) in children have been based on small/regional cohorts and practices regarding both asymptomatic screening in minors and genetic testing differ greatly between countries. To provide a global perspective, we analyzed over 2100 children and adolescents with ADPKD from 32 countries in six World Health Organization regions: 1060 children from the multi-national ADPedKD registry were compared to 269 pediatric patients from the United Kingdom (RaDaR) and 825 from the European Rare Kidney Disease Registry (ERKReg). Asymptomatic family screening was a common mode of presentation (48% in ADPedKD, 62% in ERKReg) with broad international variability (19%-75%), but fairly stable temporal trends in both registries with no correlation to genetic testing. The national rates of genetic testing varied and correlated significantly with healthcare expenditure (odds ratio 1.030 per 100 United States Dollars/capita/year, in the ERKReg cohort), with little variation over time. Diagnosis due to prenatal abnormalities was more common than anticipated at 14% increasing steadily from 2000 onward in both registries. Realistically, a high proportion of children were diagnosed with ADPKD by active screening, underlining that families affected by ADPKD have a high need for counselling on the complex issues around presymptomatic diagnosis. Regional variations in rate of genetic testing appeared to be driven by economic factors. However, large differences in rate of active screening were not correlated to healthcare spending and probably reflect the influence of different of cultural, legal and ethical frameworks on families and clinicians in different healthcare systems.
引用
- Gimpel C, Fieuws S, Hofstetter J, et al. Insights from ADPedKD, ERKReg and RaDaR registries provide a multi-national perspective on the presentation of childhood autosomal dominant polycystic kidney disease in high- and middle-income countries. Kidney Int. 2025. PMID: 40122340. doi:10.1016/j.kint.2025.02.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。